Boehringer Ingelheim develops potential treatment for severe COVID-19 complications
The FINANCIAL -- Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of ...
ADVERTISEMENT
Tag: Clinical Trial
ADVERTISEMENT
Popular Last 24h
-
A sizable percentage of internet porn users, roughly 40% are women
-
Ampersand wins £22m five-year contract at London Zoo
-
A Landmark Rolls-Ryce Debut in Georgia
-
Teaching porn literacy
-
3 New Rules To Take Control of Your Financial Future
-
Global study shows 96% plan to increase yield focus in anticipation of market correction
-
China debuts first mixed-mode autonomous railway yard to boost logistics efficiency
LATEST POSTS
LATESTBUSINESS
ADVERTISEMENT
